Evidence map›Paper›PMID 34565681›Full record

ReviewBest practice & research. Clinical endocrinology & metabolism2021

Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children.

Katherine L O'Shaughnessy, Florence Fischer, Ana C Zenclussen

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Best practice & research. Clinical endocrinology & metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07142447 (Understanding and Preventing the Impact of Endocrine Disruptors on the Hypothalamus-pituitary Axis in Sensitive Populations. Hypiend- Perinatal Study.), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07142447 narecruitingnot on this mapstarted 2025, after this paper: background citation

Understanding and Preventing the Impact of Endocrine Disruptors on the Hypothalamus-pituitary Axis in Sensitive Populations. Hypiend- Perinatal Study.

TypeinterventionalSponsorFundació Institut Germans Trias i PujolRan2025 to 2027Enrolled810ConditionsPregnancy, ChildrenArmsMulti-Component Behavioral intervention, Control group
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Current progress and research needs to protect children's environmental health.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. EndoCompass Project: Environmental Endocrinology.Hormone research in paediatrics · 2025
    Review
  9. Review
  10. Endocrine-Disrupting Chemicals and Disease Endpoints.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Katherine L O'ShaughnessyCenter for Public Health and Environmental Assessment, Public Health Integrated Toxicology Division, US Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: oshaughnessy.katie@epa.gov.
Florence FischerDepartment of Environmental Immunology, Helmholtz Centre for Environmental Research, Leipzig, Germany.
Ana C ZenclussenDepartment of Environmental Immunology, Helmholtz Centre for Environmental Research, Leipzig, Germany. Electronic address: ana.zenclussen@ufz.de.
Helmholtz Centre for Environmental Research · DEEnvironmental Protection Agency · US

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

Substances that interfere with the body's hormonal balance or their function are called endocrine disrupting chemicals (EDCs). Many EDCs are ubiquitous in the environment and are an unavoidable aspect of daily life, including during early embryogenesis. Developmental exposure to these chemicals is of critical relevance, as EDCs can permanently alter developmental programs, including those that pattern and wire the brain. Of emerging interest is how these chemicals may also affect the immune response, given the cross-talk between the endocrine and immune systems. As brain development is strongly dependent on hormones including thyroid, androgens, and estrogens, and can also be affected by immunomodulation, this complicated interplay may have long-lasting neurodevelopmental consequences. This review focuses on data available from human cohorts, in vivo models, and in vitro assays regarding the impact of EDCs after a gestational and/or lactational exposure, and how they may impact the immune system and/or neurodevelopment.

Indexed as

Endocrine DisruptorsChildEmbryonic DevelopmentFemaleHormonesHumansPregnancyEndocrine DisruptorsHormonesbisphenol A (BPA)endocrine disrupting chemicals (EDCs)immune systemneurodevelopmental disordersphthalatespoly- and perfluoroalkyl substances (PFAS)

Identifiers

PMID34565681
PMCPMC10111869
OpenAlexW3198160274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.